Persistent Systems Ltd.

Similar documents
Tata Consultancy Services

Symphony Ltd. RESULT UPDATE 31st October 2017

Tech Mahindra Ltd. RESULT UPDATE

Infibeam Incorporation Ltd.

Nestle India Ltd. RESULT UPDATE

ITC Ltd. RESULT UPDATE 27th October, 2017

HCL Technologies Ltd.

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Tech Mahindra Ltd. RESULT UPDATE

Colgate-Palmolive India Ltd.

Hindustan Unilever Ltd.

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

Britannia Industries Ltd.

Britannia Industries Ltd.

Hindustan Unilever Ltd.

Balkrishna Industries Ltd

Bharat Forge Ltd RESULT UPDATE

Bharat Forge Ltd RESULT UPDATE

Bharat Forge Ltd RESULT UPDATE

Sagar Cements Ltd. Management Meet Update

Page. ICICI Bank Ltd. RESULT UPDATE 31 st July, 2017

Lupin Ltd. RESULT UPDATE 31 st October 2017

Reliance Industries Ltd.

Godrej Consumer Products Ltd.

Page. Mahanagar Gas Ltd. RESULT UPDATE 8 th August, 2018

Lupin Ltd. RESULT UPDATE

Sun Pharmaceutical Industries Ltd.

Page. ICICI Bank Ltd. RESULT UPDATE 30 th October, 2017

Cipla Ltd. RESULT UPDATE

Visaka Industries Ltd

Kotak Mahindra Bank Ltd.

D-Link India (DLILIM) 105

Fineotex Chemical Ltd

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Cummins India Ltd Bloomberg Code: KKC IN

Ultratech Ltd. RESULT UPDATE

Sun Pharmaceutical Industries Ltd

Praj Industries (PRAIN)

Ahluwalia Contracts (India)

Bajaj Finserv (BAFINS) 5443

Simplex Infrastructures

Solar Industries India Ltd

Bajaj Finserv (BAFINS) 4375

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Wabco India (WABTVS) Having a safe and brake free ride! Management Meet Note. ICICI Securities Ltd Retail Equity Research.

Amber Enterprises India Ltd

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

Cement. Pet coke ban to dent margins in short-term. Sector Update. ICICI Securities Ltd Retail Equity Research. November 20, 2017

Bajaj Finserv (BAFINS) 3130

I Direct. nstinct. September 19, 2017

Reliance Housing Finance

Hindustan Unilever (RHS)

Minda Industries Ltd RESULT UPDATE

Lumax Industries (LUMIND)

Punjab National Bank

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

KPIT Cummins Infosystems (KPISYS)

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

UltraTech Cement (ULTCEM)

Reliance Capital (RELCAP)

Vakrangee Ltd BUY. Speciality Retail. Company Update. Aug 07, Vakrangee Ltd. Recommendation (Rs.)

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

I Direct. nstinct. November 27, 2017

IndusInd Bank (INDBA) 1717

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Colgate-Palmolive (India)

Schaeffler India (FAGBEA) 4800

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

I Direct. nstinct. February 7, 2018

Mahindra & Mahindra Ltd.

Reliance Capital (RELCAP) 549

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Bajaj Finance (BAJAF) 5498

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Tech Mahindra. Source: Company Data; PL Research

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Stock Trader: Budget Beneficiary Stock Larsen & Toubro

Union Bank of India (UNIBAN)

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Mahindra & Mahindra Ltd.

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

FY17 FY18 FY19E FY20E

He is BTech from IIT Bombay ( , Aeronautical Engineering) and MS from Cornell University ( , Mechanical Engineering).

Stock Trader - Focus on Budget: Power Grid

HCL Technologies. Rating: Target price: EPS: Target CMP. Rating. Rs. 826 REDUCE. Rs.760

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights

Hindustan Media Ventures

Stock Trader - Power Grid

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Procter & Gamble Hygiene & Health Care

Tata Consultancy Services (TCS)

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

Transcription:

RESULT UPDATE 26 th April2017

Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 India Equity Institutional Research II Result Update - Q4FY17 II 26th April, 2017 2 Investment Mode Off, Return Mode On CMP INR 564 Target INR 828 Potential Upside 47% Market Cap (INR Mn) 45424 Recommendation Buy Sector IT Result highlights Persistent reported Q4 FY17 results which were marginally below our estimates on the revenue front but beat our estimates on the profitability front. In US$ terms, the company reported revenues of US$ 109 Mn, which was 4.3% below our estimate of US$ 114 Mn largely due to decline of IP led revenues (28% to topline) by -3.7% qoq and ISV business (41.9% to revenue) by -2.3% qoq. Q4 FY17 operating margins stood at 12.5% vs our estimate of 10.2% and Q3 FY17 margins of 10.7%. We believe that margins to have significant upside as company scales up the de-linear portion of business (56.1% of revenue) Digital (18.9% of revenue) continued it s phenomenal growth trend with a 10.8% qoq growth followed by accelerite (9.6% of revenue) which grew at 10.6% qoq. MARKET DATA Shares outs (Mn) 80 EquityCap (INR Mn) 800 Mkt Cap (INR Mn) 45424 52 Wk H/L (INR) 758/501 Volume Avg (3m K) 130.86 Face Value (INR) 10 Bloomberg Code SHARE PRICE PERFORMANCE 110 PSYS IN KEY FINANCIALS Particulars (INR Mn) FY15 FY16 FY17 FY18E FY19E Net Sales 18,913 23,123 28,784 31,651 36,278 EBITDA 3,903 4,138 4,653 5,327 6,210 PAT 2,906 2,974 3,129 3,487 4,141 EPS 36.3 37.2 39.1 43.6 51.8 OPM 15.7% 13.7% 11.0% 11.6% 12.1% NPM 15.4% 12.9% 10.9% 11.0% 11.4% Margins set to improve as de-linear business scales up in FY18e Persistent s operating margins stood at 12.5%, up 175 bps qoq and 94 bps yoy largely due to scaling up of non-linear businesses such as Digital (18.9% of revenues) and accelerite (9.6% of revenues). Digital grew 10.8% qoq whereas accelerite grew 10.6% qoq in Q4FY17. Management stated that Digital could have reported a higher rate of growth, however 2 deals that were supposed to close in Q4 spilled over and will book revenues in the next quarter. 90 70 Alliance business reported a decline of -10.6% in Q4 due to seasonally weak performance of IBM. However, expect Alliance business to outperform on account on account of robust deal pipeline and IoT industry dynamics. We estimate EBITDA margins to improve from 16.2% as of FY17 to 17.1% in FY19e largely due to completion of investment phase in Alliance business. Management is upbeat on its partnership initiative with Partners Healthcare for bringing digital transformation to clinical care and agreement with USAA for security in financial services Sensex Persistent Syst MARKET INFO SENSEX 29943 NIFTY 9307 Key Concall Highlights: (i) Expect Digital to record a higher growth run-rate in Q1 FY18 as 2 deals which were to be closed in Q4 FY17 spilled over (ii) Management expects accelerite to continue it s stellar performance (iii) Revenue was impacted mainly due to 0.1% growth in Billing rate which was offset by 0.8% decline in volumes. (iv) Company maintains it s focus on de-linear business which accounts for 56% of total revenues and expects FY18e margins to be much better if not same. Valuation and view On the back of immense traction in Digital, accelerite and IBM Alliance, we expect company to deliver Revenue CAGR of ~12% between FY17 and FY19E. We estimate higher than industry average growth in the above mentioned business segments which cumulatively contribute to >56% of total revenues. We estimate Digital and Accelerite to report growth >15% yoy for the next 3 fiscal years on account robust demand environment coupled with Persistent s competency and prowess in Digital and IoT solutions and products. We have a BUY rating on the stock, assigning a P/E multiple of 16x FY19E EPS to arrive at a price target of INR 828, giving an upside potential of 47% from CMP. SHARE HOLDING PATTERN (%) Particulars Mar 17 Dec 16 Sep16 Promoters 35.02 36.21 37.86 FIIs 20.76 21.45 22.24 DIIs 14.29 13.51 12.3 12% 15% PAT CAGR between FY 17 and Others 29.93 28.83 27.61 Total 100 100 100 Revenue CAGR between FY 17 and FY 19E FY 19E

3 Q4FY17 Result Snapshot Exhibit 1 Quarterly Income Statement INR Mn Q4 Q3 Q-o-Q Q4 Y-o-Y Q4 FY17 FY17 FY17 change % FY16 change % estimates Deviation % Net Sales (US$ Mn) 109 110 (0.9%) 100 8.6% 114 (4.3%) Net Sales (INR Mn) 7,271 7,455 (2.5%) 6,771 7.4% 7,629 (4.7%) Less: Employees Remuneration & Benefits 4,882 5,182 (5.8%) 4,644 5.1% 5,339 (8.6%) Administrative & Other Expenses 1,088 1,087 0.1% 1,090 (0.2%) 1,112 (2.2%) Total Operating Expenditure 5,969 6,269 (4.8%) 5,733 4.1% 6,451 (7.5%) EBITDA 1,302 1,187 9.7% 1,038 25.4% 1,177 10.5% EBIT 908 800 13.4% 782 16.1% 781 16.2% Less: Depreciation 394 387 2.0% 256 54.0% 397 Add: Other income 143 318 (54.9%) 246 (41.8%) 325 (56.0%) Extraordinary Expense 114 Profit Before Tax 937 1,118 (16.2%) 1,028 (8.9%) 1,106 (15.3%) Adjusted Profits 1,051 1,118 (6.0%) 1,028 2.2% 1,106 Less: Total Tax 209 299 (30.2%) 220 (5.1%) 296 PAT 728 819 (11.1%) 808 (9.9%) 810 (10.2%) Adjusted PAT 842 819 2.8% 808 4.2% 810 3.9% Reported Diluted EPS (Rs.) 9.1 10.2 (11.1%) 10.1 (9.9%) 10.1 Adjusted Diluted EPS (Rs.) 10.5 10.2 2.8% 10 4.2% 10.1 3.9% No of Shared Diluted (mn) 80 80 80 80 Margin Analysis % Change Change Deviation Operating margin 12.5% 10.7% 175 11.5% 94 10.2% 225 EBIDTA Margin 17.9% 15.9% 199 15.3% 258 15.4% 247 NPM 10.0% 11.0% (97) 11.9% (192) 10.6% (61) Adjusted NPM 11.6% 11.0% 60 11.9% (35) 10.6% 96 Effective Tax Rate % 22.3% 26.7% (447) 21.4% 88 26.7% (447) Cost Analysis % Change Change Deviation Employee Cost/Net Sales 67.1% 69.5% (237) 68.6% (145) 70.0% (285) SG&A/Net sales 15.0% 14.6% 39 16.1% (113) 14.6% 39 The Tax rate for the quarter stood 22.3% in Q4FY17 DSO stood at 65 days in Q4 FY17, an improvement of 5 days from previous quarter Client engagement in the $1 Mn to $3 Mn category grew from 50 to 55 in the current quarter Attrition stood at 15.7% and has maintained its declining trend Company has Cash & Cash equivalents in the range of INR 9000 Mn

73 76 80 80 79 83 90 100 105 105 110 109 4,642 4,946 4,975 5,004 5,427 5,921 6,771 7,018 7,040 7,455 4,350 7,271 India Equity Institutional Research II Result Update - Q4FY17 II 26th April, 2017 4 Exhibit 2 Revenues and Margin Movement (INR. Bn) 8,000 25% 7,000 6,000 5,000 20% 15% 4,000 10% 3,000 2,000 1,000 5% 0% 0-5% Total Revenue(Rs Mn) Revenue Growth % EBITDA % NPM % Revenue in Rupee terms was down by 2.5% qoq at INR 7,271 Mn, and below our estimates of INR 7,629 Mn. Top-line growth was subdued mainly due to weakness in Volumes growth and weakness in Alliance business due to seasonally low performance by IBM. Operating Margin outperformed and was reported at 12.5%, which was 225 bps above our expectation of 10.2%. Management stated that it expects EBIT margins to improve over FY18-19e as investment in Alliance business is complete and as de-linear lines of business scale up over the same period. Exhibit 3 US$ Revenue and Segment Revenue Growth Analysis ($. Mn) 120 100 14% 12% 10% 80 60 40 20 0 8% 6% 4% 2% 0% -2% -4% Total Revenue(USD Mn) Revenue Growth % Dollar revenues were recorded at $109 Mn in Q4 FY17, down 0.9% qoq and up 8.6% yoy. Growth was largely impacted by slowdown in IP-Led revenues and ISV business which declined 3.7% qoq and 2.3% qoq respectively. We believe that a vibrant Digital demand environment coupled with Persistent s scale of Digital business, Digital services spread, workforce and assets provides enormous competitive over competitors.

5 Exhibit 4 Onsite Offshore Volume Growth 12,000 10,000 8,000 6,000 4,000 2,000 0 Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17 Q4FY17 20% 15% 10% 5% 0% -5% Onsite Personmonths (mn) Offshore Personmonths (mn) Onsite Vol Growth % Offshore Vol Growth % Volumes from Global Delivery Centers grew by 2% qoq, while Offshore volumes declined by 1% qoq. Utilization stood at 85.3% in Q4 vs 88.5% in Q3 FY17 with no fundamental rationale for the decline. Exhibit 5 Client Profile Client Profile Q3FY15 Q4FY15 Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2 FY17 Q3 FY17 Q4 FY17 $3 Million+ 14 14 15 17 19 18 15 15 15 15 $1 Mn - $ 3 Mn 41 48 52 46 44 42 50 51 50 55 Persistent added 5 new clients in the $1 3 Mn space thereby bringing the overall client engagements to 55. Client engagement in the $3 Mn+ category remained stagnant at 15.

6 Exhibit 6 Q4 FY17: Geography QoQ Growth (%) Geography All regions reported a flat to negative growth rate except India which grew at 0.9% qoq. North America declined by -1% qoq followed by Europe and ROW which declined by -0.9% respectively. Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 FY15 FY16 FY16 FY16 FY16 FY17 FY17 FY17 FY17 North America 1.5% -2.9% 7.8% 6.9% 13.1% 5.4% -1.4% 6.1% -1.0% Europe -3.6% -9.0% 13.9% 0.1% 19.1% -19.0% 17.8% -9.1% -0.9% India -6.1% -9.1% 4.1% 2.7% 0.9% Rest of the world -4.3% 17.1% -20.6% -84.6% 12.0% 150.3% 21.3% -6.2% -0.9% Exhibit 7 Q4 FY17: Services QoQ Growth (%) Verticals Q1 Q2 Q3 Q4 FY17 FY17 FY17 FY17 Services - -1.7% -1.5% -0.9% Digital - 7.5% 16.3% 10.8% Alliance - -1.6% 8.9% -10.6% Accelerite - 7.7% 2.2% 10.6% Digital and Accelerite outperformed with a qoq growth of 10.8% and 10.6% respectively. Alliance business disappointed in Q4 with a decline of -10.6% qoq mainly due to weak performance by IBM. Services business continues to report weak numbers due to structural weakness in the overall IT industry. However, we expect it to bounce-back in report middle single digit growth through FY18e. Exhibit 8 Q4 FY17: Industry QoQ Growth (%) Services Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 FY15 FY16 FY16 FY16 FY16 FY17 FY17 FY17 FY17 ISV 0.5% -3.1% 5.9% -3.1% 0.0% 3.4% -1.8% 0.1% -2.3% Enterprise 5.0% 0.3% 14.1% 16.2% 1.8% 5.9% 5.7% 9.5% 3.9% IP Led -4.1% -0.1% -7.1% 34.1% 57.2% 4.3% -1.0% 6.9% -3.7% ISV business declined by -2.3% qoq followed by decline in IP Led revenues by -3.7%. Enterprise revenues increased 3.9% qoq and offset the decline in other industries.

7 Exhibit 9 Q4 FY17: Profit & Loss Statement INR Mn FY15 FY16 FY17 FY18E FY19E Net Sales 18,913 23,123 28,784 31,651 36,278 SalesGrowth% 13.3% 22.3% 24.5% 10.0% 14.6% Total Revenue 18,913 23,123 28,784 31,651 36,278 Less: 12,203 15,415 19,827 21,576 24,720 EmployeesCost 2,806 3,571 4,304 4,748 5,348 SG&A 15,009 18,985 24,131 26,324 30,068 Total Operating Expenditure 3,903 4,138 4,653 5,327 6,210 EBITDA -5.8% 6.0% 12.5% 14.5% 16.6% EBITDAGrowth% 939 965 1,490 1,646 1,814 Less:Depreciation 2,965 3,173 3,163 3,681 4,396 Operating Profit -4.9% 7.0% -0.3% 16.4% 19.4% OperatingProfitGrowth% 3 1 1 0 0 Non-operatingIncome 938 784 958 950 1,088 Profit Before Tax 3,900 3,956 4,121 4,631 5,484 Tax 993 983 992 1,144 1,344 Net Profit 2,906 2,974 3,129 3,487 4,141 Adjusted Profit 2,906 2,974 3,129 3,487 4,141 Reported Diluted EPS INR 36.3 37.2 39.1 43.6 51.8 Diluted EPS Growth% -41.7% 2.3% 5.2% 11.5% 18.7% Adjusted EPS 36.3 37.2 39.1 43.6 51.8 Adjusted EPS Growth% -41.7% 2.3% 5.2% 11.5% 18.7% Exhibit 10 Q4 FY17: Balance Sheet INR Mn FY15 FY16 FY17 FY18E FY19E Liabilities Equity Capital 800 800 800 800 800 Reserves & Surplus 13,255 15,593 17,714 20,078 22,886 Equity 14,055 16,393 18,514 20,878 23,686 Net Worth 14,055 16,393 18,514 20,878 23,686 Net Deferred tax liability/(asset) 118 124 126 145 170 Total Loans 26 27 28 28 29 Capital Employed 14,200 16,544 18,667 21,052 23,885 Assets Gross Block 6,166 6,857 7,457 8,357 9,857 Less: Depreciation 3,109 3,850 5,340 6,986 8,800 Net Block 3,057 3,007 2,117 1,371 1,058 Capital WIP 40 24 29 44 41 Investments 2,129 2,218 2,480 3,043 3,644 Intangible Assets 1,019 1,597 2,015 2,216 2,539 Others Assets 315 233 290 319 365 Current Assets Sundry Debtors 3,586 4,275 5,126 5,636 6,460 Current Investments 4,620 4,828 6,045 6,647 7,604 Cash and Bank Balance 1,416 1,432 1,949 3,620 4,438 Loans and Advances 531 1,663 2,071 1,918 1,959 Other Current Assets 1,035 1,788 1,786 2,048 2,468 Total Current Assets 11,188 13,987 16,976 19,869 22,928 Less:Current Liabilities & Provisions Sundry Creditors 529 1,651 1,983 2,164 2,471 Provisions 1,755 1,224 1,235 1,424 1,673 Other Current Liabilities 1,265 1,647 2,020 2,222 2,546

8 Exhibit 11 Q4 FY17: Ratio Analysis INR Mn FY15 FY16 FY17 FY18E FY19E EBITDA Margin(%) 20.6% 17.9% 16.2% 16.8% 17.1% Tax/PBT(%) 25.5% 24.8% 24.1% 24.7% 24.5% Net Profit Margin(%) 15.4% 12.9% 10.9% 11.0% 11.4% RoE(%) 22.1% 19.5% 17.9% 17.7% 18.6% RoCE(%) 21.7% 19.3% 17.8% 17.6% 18.4% Current Ratio(x) 3.2x 3.1x 3.2x 3.4x 3.4x Dividend Payout(%) 31.2% 28.6% 32.2% 32.2% 32.2% Book Value Per Share(Rs.) 175.7 204.9 231.4 261.0 296.1 Financial Leverage Ratios Debt/Equity(x) 0.0x 0.0x 0.0x 0.0x 0.0x Growth Indicators% Growth in Gross Block(%) 11.8% 11.2% 8.8% 12.1% 17.9% Sales Growth(%) 13.3% 22.3% 24.5% 10.0% 14.6% EBITDA Growth(%) (5.8%) 6.0% 12.5% 14.5% 16.6% Net Profit Growth(%) 16.6% 2.3% 5.2% 11.5% 18.7% Diluted EPS Growth(%) (41.7%) 2.3% 5.2% 11.5% 18.7% Turnover Ratios Debtors (Days of net sales) 64 62 60 62 61 Exhibit 12 Q4 FY17: Free Cash Flow Analysis INR Mn FY15 FY16 FY17 FY18E FY19E PAT 2,906.3 2,973.6 3,128.8 3,487.0 4,140.6 (Less)/Add: Extraordinary Income/Expense 0.0 0.0 0.0 0.0 0.0 Less: Non Operating Income (938.2) (784.5) (958.5) (949.5) (1,088.3) Add: Depreciation 938.5 965.2 1,490.2 1,645.9 1,813.9 Add: Interest Paid 3.4 0.9 0.9 0.0 0.0 Operating Profit before Working Capital Changes 2,910.1 3,155.2 3,661.4 4,183.4 4,866.2 (Inc)/Dec in Current Assets (1,221.7) (2,782.8) (2,472.9) (1,222.0) (2,241.4) Inc/(Dec) in Current Liabilities 764.0 972.5 717.9 570.4 881.3 Net Cash Generated From Operations 2,452.3 1,344.9 1,906.4 3,531.8 3,506.1 Cash Flow from Investing Activities (Inc)/Dec in Fixed Assets (649.3) (690.7) (600.0) (900.0) (1,500.0) (Inc)/Dec in Capital Work In Progress 267.4 16.4 (5.1) (14.9) 2.5 (Inc)/Dec in Investment (Strategic) (1,292.3) 767.6 (500.0) (500.0) (500.0) (Inc)/Dec in Investment (Others) 446.1 (856.7) 238.2 (62.9) (101.6) Add: Non Operating Income Income 938.2 784.5 958.5 949.5 1,088.3 (Inc)/Dec in Intangible Assets 217.5 (495.0) (475.0) (229.5) (370.5) Net Cash Flow from/(used in) Investing Activities (72.5) (473.9) (383.5) (757.8) (1,381.2) Cash Flow from Financing Activities Inc/(Dec) in Total Loans (281.0) 6.6 1.9 19.9 26.0 Dividend Paid (800.0) (640.0) (876.1) (976.4) (1,159.4) Tax Paid on Dividend (107.2) (211.7) (131.4) (146.5) (173.9) Less: Interest Paid (3.4) (0.9) (0.9) 0.0 0.0 Net Cash Flow from Financing Activities (1,920.1) (854.9) (1,006.5) (1,102.9) (1,307.3) Net Inc/Dec in cash equivalents 459.7 16.1 516.4 1,671.1 817.7 Opening Balance 956.5 1,416.2 1,432.4 1,948.8 3,619.8 Closing Balance Cash and Cash Equivalents 1,416.2 1,432.4 1,948.8 3,619.8 4,437.5

9 Rating Legend Date CMP (INR) TP (INR) Recommendation Our Rating Upside 26-Apr-17 564 828 BUY Buy More than 15% 08-Mar-17 616 835 BUY Accumulate 5% 15% Hold 0 5% Reduce -5% 0 Sell Less than 5% CERTIFICATION: I, Mayank Babla (MCom & BSc Economics & Management), research analyst, author and the name subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my views about the subject issuer(s) or securities. I also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & Conditions and other disclosures: KRChoksey Shares and Securities Pvt. Ltd (hereinafter referred to as KRCSSPL) is a registered member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and MCX Stock Exchange Limited. KRCSSPL is a registered Research Entity vide SEBI Registration No. INH000001295 under SEBI (Research Analyst) Regulations, 2014. We submit that no material disciplinary action has been taken on KRCSSPL and its associates (Group Companies) by any Regulatory Authority impacting Equity Research Analysis activities. KRCSSPL prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or derivatives of any companies that the analyst covers. The information and opinions in this report have been prepared by KRCSSPL and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of KRCSSPL. While we would endeavor to update the information herein on a reasonable basis, KRCSSPL is not under any obligation to update the information. Also, there may be regulatory, compliance or other reasons that may prevent KRCSSPL from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or KRCSSPL policies, in circumstances where KRCSSPL might be acting in an advisory capacity to this company, or in certain other circumstances. This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. KRCSSPL will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. KRCSSPL accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. Our employees in sales and marketing team, dealers and other professionals may provide oral or written market commentary or trading strategies that reflect opinions that are contrary to the opinions expressed herein,.in reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest. Associates (Group Companies) of KRCSSPL might have received any commission/compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of brokerage services or specific transaction or for products and services other than brokerage services. KRCSSPL or its Associates (Group Companies) have not managed or co-managed public offering of securities for the subject company in the past twelve months KRCSSPL encourages the practice of giving independent opinion in research report preparation by the analyst and thus strives to minimize the conflict in preparation of research report. KRCSSPL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither KRCSSPL nor Research Analysts have any material conflict of interest at the time of publication of this report. It is confirmed that, Mayank Babla (MCom & BSc Economics & Management), research analyst, of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months. Compensation of our Research Analysts is not based on any specific brokerage service transactions. KRCSSPL or its associates (Group Companies) collectively or its research analyst do not hold any financial interest/beneficial ownership of more than 1% (at the end of the month immediately preceding the date of publication of the research report) in the company covered by Analyst, and has not been engaged in market making activity of the company covered by research analyst. Since associates (Group Companies) of KRCSSPL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. It is confirmed that, Mayank Babla (MCom & BSc Economics & Management), research analyst, do not serve as an officer, director or employee of the companies mentioned in the report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject KRCSSPL and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Please send your feedback to research.insti@krchoksey.com Visit us at Kisan Ratilal Choksey Shares and Securities Pvt. Ltd Registered Office: 1102, Stock Exchange Tower, Dalal Street, Fort, Mumbai 400 001. Phone: 91-22-6633 5000; Fax: 91-22-6633 8060. Corporate Office: ABHISHEK, 5th Floor, Link Road, Andheri (W), Mumbai 400 053. Phone: 91-22-6696 5555; Fax: 91-22-6691 9576.